| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...512894Y |
| P356 | DOI | 10.1371/JOURNAL.PONE.0012894 |
| P953 | full work available at URL | http://dx.plos.org/10.1371/journal.pone.0012894 |
| https://europepmc.org/articles/PMC2943924 | ||
| https://europepmc.org/articles/PMC2943924?pdf=render | ||
| https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012894&type=printable | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20877570/?tool=EBI | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20877570/pdf/?tool=EBI | ||
| P932 | PMC publication ID | 2943924 |
| P698 | PubMed publication ID | 20877570 |
| P5875 | ResearchGate publication ID | 46579663 |
| P2093 | author name string | Nobuhiko Katunuma | |
| Naozumi Ishimaru | |||
| Yoshio Hayashi | |||
| Rieko Arakaki | |||
| Akiko Yamada | |||
| P2860 | cites work | Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice | Q61140426 |
| Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide | Q70765881 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| A selective inhibitor of dipeptidyl peptidase I impairs generation of CD8+ T cell cytotoxic effector function | Q73369992 | ||
| Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells | Q73622000 | ||
| Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice | Q74595052 | ||
| Control of intestinal inflammation by regulatory T cells | Q77291202 | ||
| Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells | Q79326703 | ||
| Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex | Q27620728 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| Where CD4+CD25+ T reg cells impinge on autoimmune diabetes | Q28506933 | ||
| Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity | Q28591251 | ||
| Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus | Q28613227 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse | Q33653550 | ||
| Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
| The NOD mouse model of type 1 diabetes: as good as it gets? | Q33865111 | ||
| Cathepsin L is essential for onset of autoimmune diabetes in NOD mice | Q34014524 | ||
| The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. | Q34452348 | ||
| Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
| Cathepsin L activity controls adipogenesis and glucose tolerance | Q34654358 | ||
| Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes | Q34756826 | ||
| Processing and activation of lysosomal proteinases | Q35055169 | ||
| Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo | Q35558255 | ||
| The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice | Q36079920 | ||
| The lysosomal cysteine proteases in MHC class II antigen presentation | Q36266499 | ||
| The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes | Q36266503 | ||
| Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands | Q36370268 | ||
| In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
| CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion | Q36399063 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| The role of cystatins in cells of the immune system | Q36650672 | ||
| Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes | Q36755911 | ||
| Cathepsins: key modulators of cell death and inflammatory responses | Q37257916 | ||
| Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo | Q37346696 | ||
| Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications | Q37512877 | ||
| Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass | Q40116203 | ||
| A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation | Q40746014 | ||
| MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity | Q40790715 | ||
| Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation. | Q41031849 | ||
| The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells | Q41255658 | ||
| Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. | Q41335222 | ||
| Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes. | Q42511999 | ||
| Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens | Q43591493 | ||
| Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing | Q43591595 | ||
| Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus | Q43863707 | ||
| Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis | Q45232044 | ||
| Drak2 overexpression results in increased beta-cell apoptosis after free fatty acid stimulation | Q46382236 | ||
| Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. | Q52584877 | ||
| DcR3/TR6 Effectively Prevents Islet Primary Nonfunction After Transplantation | Q58088388 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e12894 | |
| P577 | publication date | 2010-09-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity | |
| Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8+ T Cell Activity | |||
| P478 | volume | 5 |
| Q34880003 | A small interfering RNA targeting Lnk accelerates bone fracture healing with early neovascularization. |
| Q36543714 | Anti-serpin antibody-mediated regulation of proteases in autoimmune diabetes |
| Q33920338 | Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models. |
| Q52573372 | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. |
| Q35098737 | Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases |
| Q47101639 | Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes |
| Q36016293 | Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes |
| Q58066739 | HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction |
| Q64071659 | Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells |
| Q93064841 | Lysosomes as a therapeutic target |
| Q34983677 | Testing agents for prevention or reversal of type 1 diabetes in rodents |
| Q38235294 | The Roles of Lysosomes in Inflammation and Autoimmune Diseases |
Search more.